Guidance On NDA OTC Reportable Label Changes Among US FDA's Planned For 2021

 
• By Sue Sutter
  
To do list
FDA's drugs center is out with its annual guidance "to do" list.
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation